Pfizer Seeks Cooperation, Announces Whitening Drug

Ever since Wei Kang revealed actual patient cases, no one dared question the authenticity of the clinical trial reports again.

After all, they could see with their own eyes how patients who had been ravaged by cancer until they were physically and mentally exhausted, barely recognizable as human, visibly regained their health and vitality after taking the new drug.

These vivid, real cases left people deeply shaken.

Previously, they had only seen Cao Jinmei's story online.

Though it had been equally shocking, the impact had been limited. After all, which of these pharmaceutical experts had not seen hundreds or thousands of cancer patients?

Especially the international pharmaceutical giants—which of them did not have several drugs capable of curing cancer?

They had long grown accustomed to the life and death of cancer patients.

Yet today, when they saw these patients undergo a complete transformation and regain their health in just a few days, they could not help but be struck by a soul-searching shock.

Everyone stared intently at the cases replaying on the screen, studying them carefully.

For a moment, an eerie silence fell over the venue.

Wei Kang was the one who finally broke the silence. He spoke.

"Alright, that concludes the matter of the anti-cancer drugs. Next, we have another newly developed drug to announce."

The entire audience immediately perked up and looked toward Wei Kang, waiting for him to continue.

The gazes of the pharmaceutical industry representatives carried both shock and a hint of anticipation.

Having already witnessed the effects of the New Anti-Cancer Drug, they had silently acknowledged Sanqing Pharmaceutical's capabilities.

Now that they heard another new drug was about to be announced, they all began to speculate.

Was it a heart disease drug? Or a cerebrovascular drug?

Could it be a neurological treatment drug? Or perhaps some kind of cellular immunotherapy drug?

The media, meanwhile, were brimming with excitement. They all felt their trip had been worthwhile. Sanqing Pharmaceutical's R&D capabilities were actually this astonishing—releasing two self-developed drugs in succession was simply terrifying.

Wei Kang switched the projected materials as he gave a detailed introduction.

"What we're announcing this time is a whitening and spot-removing drug. Its main effects are to inhibit the production of melanin in the skin and break down melanin deposits in the deeper layers of the skin, thereby evening out skin tone within one to two weeks and completely eliminating dark spots."

"Here are the Phase I and Phase II clinical trial reports. As you can see..."

Yet as Wei Kang continued his explanation, the expressions of the people below the stage became somewhat strange.

The pharmaceutical representatives' expressions shifted from shock to disappointment, then gradually to disdain.

As expected, self-developing new drugs was still too difficult. Sanqing Pharmaceutical had run out of steam and could not continuously develop new drugs, so it could only turn its efforts toward lowbrow cosmetic and health products like whitening and spot-removing drugs.

There was, in fact, a so-called hierarchy of disdain within the pharmaceutical industry as well.

Just as surgeons looked down on cosmetic surgeons, pharmaceutical experts did not think much of their peers who worked on beauty products.

Drug development was such a lofty undertaking. Anti-cancer drugs, cardiovascular and cerebrovascular drugs, AIDS treatment drugs, and so on—every one of these drugs, once developed, could save countless lives and benefit all humanity.

But beauty products? What were they? Heh heh, they were nothing more than products sold on dreams of beauty.

They might not even compare to placebos. At least placebos were free and would not disfigure anyone.

The pharmaceutical representatives gradually stopped paying attention to the materials on the screen and began discussing other topics among themselves.

However, the media reporters seated in the front rows wore expressions of immense delight.

Quite a few female reporters even let out repeated cries of surprise.

Most media reporters were ordinary people, so they were better able to view this drug from an ordinary person's perspective.

They had keen news instincts.

Whitening drugs might not sound particularly lofty, nor could they save lives.

Yet the saying, "Fair skin conceals a hundred flaws," was so deeply ingrained in people's hearts. It perfectly captured just how fanatical and persistent Easterners were in their pursuit of snow-white skin.

Every media professional knew just how many crazy things women could do in order to become beautiful.

Every year, stories of young women suffering botched cosmetic procedures at beauty salons emerged one after another.

In every upscale downtown shopping mall, the most prominent prime locations on the first floor were reserved for major skincare brands.

Oulaiya earned tens of billions of US dollars a year from cosmetics alone and had entered the Fortune Global 500.

Therefore, a whitening drug with astonishing effects would absolutely cause a sensation.

Thus, the reporters began asking questions one after another.

"Sanqing is a pharmaceutical company. Does its development of whitening drugs mean it intends to enter the cosmetics market?"

"We heard that you also serve as Sanqing Pharmaceutical's R&D director. Were both of these drugs developed under your leadership?"

"Has Sanqing already decided on the direction of its next self-developed drug?"

The media's enthusiasm stood in stark contrast to the indifference of the pharmaceutical representatives.

Wei Kang took all of it in.

But he did not care. In any case, this whitening drug had not been introduced for the pharmaceutical companies.

As long as the media reported the results, there was no fear that it would fail to attract widespread public attention.

That would draw the attention of cosmetics giants.

Very soon, the introduction to the whitening drug was over.

Wei Kang was about to announce the successful conclusion of the press conference.

Suddenly, Dr. Andre, Pfizer Inc.'s Asia-Pacific president, stood up.

He seemed to have been waiting for a long time and could no longer contain his impatience. He looked straight at the stage.

"Mr. Wei, Pfizer Inc. is very interested in the New Anti-Cancer Drug your company developed. Could we discuss a partnership?"

At that moment, General Manager Wu, who was sitting nearby, looked at Andre in disbelief. He vaguely seemed to hear a crack—the sound of his heart breaking.

The moment Andre spoke of cooperation, everyone was stunned.

This meant that Andre had publicly acknowledged the effectiveness of Sanqing Pharmaceutical's New Anti-Cancer Drug.

Even the Asia-Pacific president of Pfizer Inc., the world's number-one pharmaceutical company, had acknowledged it. Who else could object?

Would they jump out like Schmitz from Merck, randomly pick faults, and then be left speechless by the rebuttal?

Wouldn't that make them the laughingstock of the entire industry?

Very quickly, some people realized: why should Pfizer Inc. be the only one allowed to cooperate? They could propose cooperation too.

Besides, there were so many domestic pharmaceutical companies. They all knew one another well, had dealt with each other before, and had a stronger foundation for cooperation.

A representative from a Haishi pharmaceutical company stood up. "President Wei, we met at a pharmaceutical exhibition three months ago. Later, we even had dinner together. Do you still remember me?"

Wei Kang nodded with a smile. "Of course I remember. President Li of Haishi Taiji Pharmaceutical—you even introduced a business deal to us at the dinner. I remember you had an excellent capacity for alcohol. You drank all night without getting drunk at all. We have another dinner arranged shortly, so please do honor us with your presence."

President Li was instantly overjoyed. President Wei actually remembered me so well? He even remembered details like that. It looked like there was room to further build our relationship.

The representatives of the other pharmaceutical companies seemed to suddenly wake up. They immediately rose to their feet one after another and expressed their willingness to cooperate.

"President Wei, our company is very interested in your company's New Anti-Cancer Drug. May we participate in the follow-up project collaboration? The terms can be discussed in detail. We definitely won't disappoint you."

A large crowd instantly surged toward the stage, surrounding Wei Kang and Sun Chengren.

Even the representatives of foreign pharmaceutical giants squeezed in after Andre from Pfizer Inc.

Schmitz of Merck looked terrifyingly grim. Without saying a word, he turned and left, naturally not forgetting to take the thick clinical data report with him.

The Roche Pharmaceuticals representative left with him as well.

The media reporters were all pushed out of the way. They could only raise their cameras and keep taking pictures, recording the lively moment.

Wei Kang picked up the microphone and said with a smile, "Everyone, please quiet down. There's no need to rush."

"Today's press conference ends here. We have arranged a dinner next, so please take the cars to the restaurant and dine with us."

"Whatever it is, we can discuss it in detail after the meal."